

Developer of immuno-therapies and vaccines for infectious diseases. The company engages in research and development of vaccines for the treatment and prevention of life-threatening infectious diseases. Among its major competitors, Bavarian Nordic is ranked in 4th place for NPS while Ambu is 1st, and Biogen is 2nd.
Bavarian Nordic's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether Bavarian Nordic's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 0% | Passives |
| 100% | Detractors |
| Summary | Date | Score |
|---|---|---|
Oct 2023 -100 | Oct 2023 | -100 |
Bavarian Nordic is ranked second for NPS among its competitors. Biogen and MyoKardia come in first and third, with Reata Pharmaceuticals coming in at #4.
![]() Bavarian Nordic | ![]() Biogen | ![]() MyoKardia | ![]() Reata Pharmaceuticals | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | -100 | 21 | - | - |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | Neutral | - |
| Valuation Updated every 24 hours for public companies | - | $42.46B | $11.99B | $2.95B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Bavarian Nordic's NPS is rated right below GN Store Nord.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Ambu | 100 |
![]() | Biogen | 21 |
![]() | Genmab | 18 |
![]() | MyoKardia | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | GN Store Nord | N/A |
![]() | Bavarian Nordic | -100 |
Bavarian Nordic scored a -100 for both Net Promoter Score and Employee Net Promoter Score. NPS gauges how likely a customer of Bavarian Nordic would recommend the brand to a friend. ENPS measures how likely Bavarian Nordic employees would recommend working at Bavarian Nordic to a friend.
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |